Breaking News Instant updates and real-time market news.

EPAY

Bottomline Technologies

$36.96

0.67 (1.85%)

04:55
02/15/18
02/15
04:55
02/15/18
04:55

Bottomline Technologies management to meet with Needham

Meetings to be held in the Midwest on February 14-15 hosted by Needham.

  • 15

    Feb

  • 22

    Feb

  • 15

    Mar

EPAY Bottomline Technologies
$36.96

0.67 (1.85%)

07/17/17
07/17/17
UPGRADE
Target $33

Outperform
Follow-up: Bottomline Technologies upgraded to Outperform at Raymond James
As previously reported, Raymond James upgraded Bottomline Technologies to Outperform from Market Perform and established a $33 price target. Analyst Wayne Johnson thinks the company is entering a period of high margins and more linear revenue growth and is excited about positive operating leverage from rising sales momentum and contracts that have already been expensed over a fixed cost infrastructure.
07/17/17
07/17/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. United Rentals (URI) upgraded to Outperform from Sector Perform at RBC Capital with analyst Seth Weber citing consolidation within the rental space and positive comments by rental company Sunbelt as two reasons for the upgrade. 2. Fifth Street Finance (FSC) upgraded to Outperform from Market Perform at JMP Securities with analyst Christopher York saying that the deal under which Oaktree (OAK) will become Fifth Street's investment adviser will improve both companies' corporate governance and lower Fifth Street's costs. 3. CACI (CACI) upgraded to Buy from Hold at Jefferies with analyst Sheila Kahyaoglu saying she views the company's portfolio geared towards defense solutions as "compelling" and she likes its "aggressive" capital deployment strategy. 4. Greenbrier (GBX) upgraded to Buy from Hold at Stifel with analyst Michael Baudendistel saying that the market is underestimating the benefits of the company's deal with Mitsubishi UFJ Lease & Finance and its international expansion. 5. Bottomline Technologies (EPAY) upgraded to Outperform from Market Perform at Raymond James with analyst Wayne Johnson saying he thinks the company is entering a period of high margins and more linear revenue growth and is excited about positive operating leverage from rising sales momentum and contracts that have already been expensed over a fixed cost infrastructure. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/11/17
CHLM
08/11/17
UPGRADE
Target $35
CHLM
Buy
Bottomline Technologies upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum analyst George Sutton upgraded Bottomline Technologies to Buy from Hold, stating that after "waiting" nearly two years for, all of its assets are now moving in an upward direction and he sees growth rates remaining at the upper end of the 15-20% subscription and transaction growth guidance. Sutton raised his price target on Bottomline shares to $35 from $26.
02/02/18
NEED
02/02/18
NO CHANGE
Target $45
NEED
Buy
Bottomline Technologies price target raised to $45 from $38 at Needham
Needham analyst Mayank Tandon raised his price target on Bottomline Technologies to $45 and kept his Buy rating after a Q2 beat on earnings, revenue, and EBITDA. The analyst says the quarter was highlighted by solid growth in subscription and transaction revenue along with margin expansion, adding that the company's competitive strengths on the corporate banking side position it well to execute over medium to long-term.

TODAY'S FREE FLY STORIES

AAPL

Apple

$195.07

6.93 (3.68%)

06:01
03/22/19
03/22
06:01
03/22/19
06:01
Periodicals
Apple signs Vox to be part of news subscription service, Bloomberg reports »

Apple has signed Vox to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

LIND

Lindblad Expeditions

$15.18

-0.12 (-0.78%)

05:55
03/22/19
03/22
05:55
03/22/19
05:55
Conference/Events
Lindblad Expeditions management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

DRI

Darden

$116.11

7.485 (6.89%)

05:53
03/22/19
03/22
05:53
03/22/19
05:53
Recommendations
Darden analyst commentary  »

Darden price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMC

Commercial Metals

$17.35

1.29 (8.03%)

05:43
03/22/19
03/22
05:43
03/22/19
05:43
Upgrade
Commercial Metals rating change  »

Commercial Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$134.59

2.69 (2.04%)

05:42
03/22/19
03/22
05:42
03/22/19
05:42
Upgrade
Stanley Black & Decker rating change  »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 24

    Apr

BIIB

Biogen

$226.71

-93.76 (-29.26%)

05:42
03/22/19
03/22
05:42
03/22/19
05:42
Downgrade
Biogen rating change  »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

BBY

Best Buy

$70.56

1.44 (2.08%)

05:41
03/22/19
03/22
05:41
03/22/19
05:41
Upgrade
Best Buy rating change  »

Best Buy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VAR

Varian Medical

$137.77

1.97 (1.45%)

05:41
03/22/19
03/22
05:41
03/22/19
05:41
Upgrade
Varian Medical rating change  »

Varian Medical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

BIIB

Biogen

$226.71

-93.76 (-29.26%)

05:41
03/22/19
03/22
05:41
03/22/19
05:41
Downgrade
Biogen rating change at Citi »

Citi downgrades Biogen to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

FTI

TechnipFMC

$23.83

0.09 (0.38%)

05:40
03/22/19
03/22
05:40
03/22/19
05:40
Upgrade
TechnipFMC rating change  »

TechnipFMC upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

RYB

RYB Education

$8.01

0.09 (1.14%)

05:40
03/22/19
03/22
05:40
03/22/19
05:40
Downgrade
RYB Education rating change  »

RYB Education downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOV

Spark Networks

$11.29

(0.00%)

05:26
03/22/19
03/22
05:26
03/22/19
05:26
Conference/Events
Spark Networks to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

ESALY

Eisai

$0.00

(0.00%)

05:25
03/22/19
03/22
05:25
03/22/19
05:25
Downgrade
Eisai rating change  »

Eisai downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESALY

Eisai

$0.00

(0.00%)

, BIIB

Biogen

$226.71

-93.76 (-29.26%)

05:24
03/22/19
03/22
05:24
03/22/19
05:24
Hot Stocks
Eisai announces initiation of Phase III BAN2401 study in Alzheimer's disease »

Eisai (ESALY) announced…

ESALY

Eisai

$0.00

(0.00%)

BIIB

Biogen

$226.71

-93.76 (-29.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

ZUO

Zuora

$24.34

0.62 (2.61%)

05:18
03/22/19
03/22
05:18
03/22/19
05:18
Recommendations
Zuora analyst commentary at Jefferies »

Zuora business metrics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

OPHRY

Ophir Energy

$0.00

(0.00%)

05:15
03/22/19
03/22
05:15
03/22/19
05:15
Downgrade
Ophir Energy rating change  »

Ophir Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TELNY

Telenor

$0.00

(0.00%)

05:13
03/22/19
03/22
05:13
03/22/19
05:13
Downgrade
Telenor rating change  »

Telenor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KGFHY

Kingfisher

$0.00

(0.00%)

05:13
03/22/19
03/22
05:13
03/22/19
05:13
Downgrade
Kingfisher rating change  »

Kingfisher downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$31.29

0.78 (2.56%)

05:11
03/22/19
03/22
05:11
03/22/19
05:11
Earnings
Health Insurance confirms 2019 outlook, calls shares 'compelling value' »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

HIIQ

Health Insurance Innovations

$31.29

0.78 (2.56%)

05:07
03/22/19
03/22
05:07
03/22/19
05:07
Hot Stocks
Health Insurance CEO says multi-state regulatory review found no issues »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

PSO

Pearson

$10.96

0.07 (0.64%)

05:02
03/22/19
03/22
05:02
03/22/19
05:02
Upgrade
Pearson rating change  »

Pearson upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LITE

Lumentum

$52.05

2.395 (4.82%)

04:59
03/22/19
03/22
04:59
03/22/19
04:59
Upgrade
Lumentum rating change at JPMorgan »

Lumentum upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

PPG

PPG

$112.60

1.73 (1.56%)

04:58
03/22/19
03/22
04:58
03/22/19
04:58
Downgrade
PPG rating change at JPMorgan »

PPG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

SHW

Sherwin-Williams

$433.70

4.385 (1.02%)

04:57
03/22/19
03/22
04:57
03/22/19
04:57
Downgrade
Sherwin-Williams rating change at JPMorgan »

Sherwin-Williams…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

MDB

MongoDB

$154.52

10.73 (7.46%)

04:55
03/22/19
03/22
04:55
03/22/19
04:55
Initiation
MongoDB initiated at William Blair »

MongoDB initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.